비교리스트

 카트 문의
시장보고서
상품코드
1566371

세계의 말 헬스케어 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 제품별, 적응증별, 활동별, 유통 채널별, 지역별 시장 예측(2024-2032년)

Equine Healthcare Market Size, Share, Trends, Industry Analysis Report: By Product, Indication, Activity, Distribution Channel, and Region - Market Forecast, 2024-2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 116 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계 말 헬스케어 시장 규모는 2032년까지 66억 5,000만 달러에 이를 전망입니다. 이 보고서는 현재 시장 역학을 상세하게 통찰하고 미래 시장 성장에 대한 분석을 제공합니다.

세계 말의 수가 증가하고 있다는 것은 세계 말 헬스케어 시장을 뒷받침하고 있습니다. 말의 마리 수가 증가하면 질병, 부상, 지속적인 증상 등 다양한 건강 문제가 발생합니다. 그 결과, 진단 서비스, 치료, 전문 케어에 대한 요구가 높아지고, 말 헬스케어 전문가나 시설에 대한 수요가 증가하고 있습니다.

연구개발에 대한 주력이 높아지면서 말 헬스케어 시장을 견인하고 있습니다. R&D 활동은 말 건강을 위한 새로운 치료법, 치료법 및 진단 장비를 생성할 수 있습니다. 이러한 진보가 이용하기 쉬워지면, 마주나 수의사는 그것을 추구하는 경향이 강해져, 말 헬스케어 서비스 수요가 높아지게 됩니다.

말 헬스케어 시장 보고서 하이라이트

적응증별로는 기생충이 말의 건강에 널리 영향을 주고 있기 때문에 기생충 감염증 분야가 2023년에 가장 큰 시장 점유율을 차지했습니다. 또, 정기적인 기생충 관리의 중요성에 대한 마주의 의식이 높아지고 있는 것도, 이 분야의 우위성을 뒷받침하고 있습니다.

유통 채널별로 전자상거래 부문이 예측 기간 동안 가장 높은 성장을 이룰 것으로 예상됩니다.

동물 병원 및 클리닉 부문은 말의 종합적인 관리를 제공하는 데 필수적인 역할을 했기 때문에 2023년에 가장 큰 시장 점유율을 차지했습니다. 이러한 기관에서 사용할 수 있는 광범위한 인프라, 전문 직원 및 고급 장비가 더욱 우위에 기여하고 있습니다.

북미는 첨단 수의학 인프라, 말 건강에 대한 높은 수준의 투자, 주요 제약 기업 및 생명 공학 기업의 중요한 존재로 조사 기간 동안 가장 빠른 성장을 기록할 것으로 예상됩니다.

아시아태평양 시장은 말의 건강 인프라에 대한 투자 증가, 동물 복지에 대한 의식 증가, 중국과 호주와 같은 국가에서의 마술 산업 확대로 추정 및 예측 기간 동안 현저한 CAGR로 확대될 것으로 예측됩니다.

Zoetis Services LLC, Arthrex Inc., Dechra, Ceva Sante Animale, Merck & Co., Inc., Heska Corporation, Hallmarq Veterinary Imaging, ESAOTE SPA, Vetoquinol SA, IDEXX Laboratories, Inc., Elanco, Covetrus Inc., Cargill 및 Biosig Instruments Inc.는 말 헬스케어 시장에서 세계 기업입니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 말 헬스케어 시장 인사이트

  • 시장 현황
  • 말 헬스케어 시장 역학
    • 성장 촉진요인과 기회
      • 말의 마리 수 증가가 시장을 견인하고 있다
      • 말의 건강에 있어서의 인공지능(AI)의 출현이 시장을 견인
    • 억제요인과 과제
      • 치료에 드는 고액의 비용이 시장의 성장을 방해하고 있다
  • PESTEL 분석
  • 말 헬스케어 시장 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계 말 헬스케어 시장 : 제품별

  • 주요 조사 결과
  • 소개
  • 백신
  • 의약품
  • 의약품 사료 첨가물
  • 오소바이오로직스
  • 진단
  • 소프트웨어
  • 기타

제6장 세계 말 헬스케어 시장 : 적응증별

  • 주요 조사 결과
  • 소개
  • 근골격 장애
  • 기생충 감염증
  • 말 헤르페스 바이러스
  • 말 바이러스성 동맥염(EVA)
  • 말 인플루엔자
  • 웨스트나일 바이러스
  • 파상풍
  • 기타

제7장 세계 말 헬스케어 시장 : 활동별

  • 주요 조사 결과
  • 소개
  • 스포츠/레이스
  • 레크리에이션
  • 기타

제8장 세계 말 헬스케어 시장 : 유통 채널별

  • 주요 조사 결과
  • 소개
  • 동물병원 및 클리닉
  • 전자상거래
  • 승마시설
  • 기타

제9장 세계 말 헬스케어 시장 : 지역별

  • 주요 조사 결과
  • 소개
    • 말 헬스케어 시장의 평가 : 지역, 2019-2032년
  • 북미
    • 북미 : 제품별, 2019-2032년
    • 북미 : 적응증별, 2019-2032년
    • 북미 : 활동별, 2019-2032년
    • 북미 : 유통 채널별, 2019-2032년
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 제품별, 2019-2032년
    • 유럽 : 증상별, 2019-2032년
    • 유럽 : 활동별, 2019-2032년
    • 유럽 : 유통 채널별, 2019-2032년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양: 제품별, 2019-2032년
    • 아시아태평양: 적응증별, 2019-2032년
    • 아시아태평양: 활동별, 2019-2032년
    • 아시아태평양: 유통 채널별, 2019-2032년
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카: 제품별, 2019-2032년
    • 중동 및 아프리카 : 적응증별, 2019-2032년
    • 중동 및 아프리카 : 활동별, 2019-2032년
    • 중동 및 아프리카 : 유통 채널별, 2019-2032년
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 제품별, 2019-2032년
    • 라틴아메리카 : 적응증별, 2019-2032년
    • 라틴아메리카: 활동별, 2019-2032년
    • 라틴아메리카 : 유통 채널별, 2019-2032년
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제10장 경쟁 구도

  • 확대와 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제11장 기업 프로파일

  • Zoetis Services LLC
  • Arthrex Inc.
  • Dechra
  • Ceva Sante Animale
  • Merck & Co., Inc.
  • Heska Corporation
  • Hallmarq Veterinary Imaging
  • ESAOTE SPA
  • Vetoquinol SA
  • IDEXX Laboratories, Inc.
  • Elanco
  • Covetrus Inc
  • Cargill
  • Biosig Instruments Inc.
JHS 24.10.24

The global equine healthcare market size is expected to reach USD 6.65 billion by 2032, according to a new study by Polaris Market Research. The report "Equine Healthcare Market Size, Share, Trends, Industry Analysis Report - By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software, and Others), Indication, Activity, Distribution Channel, and Region; Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising population of horses worldwide propels the global equine healthcare market. A larger horse population results in various health issues such as diseases, injuries, and persistent conditions. As a result, there is a growing requirement for diagnostic services, treatments, and specialized care, creating an increased demand for equine healthcare professionals and facilities.

The increasing focus on research and development is driving the equine healthcare market. Research and development activities can result in the creation of new treatments, therapies, and diagnostic equipment for equine well-being. As these advancements become accessible, horse owners and veterinarians are more inclined to pursue them, leading to a higher demand for equine healthcare services.

Equine Healthcare Market Report Highlights

By indication, the parasite infections segment accounted for the largest market share in 2023, owing to the widespread impact of parasites on horse health. Additionally, increased awareness among horse owners about the importance of regular parasite management drives segment dominance.

The e-commerce segment, in terms of distribution channel, is expected to witness the highest growth during the forecast period, owing to the increasing adoption of online platforms for purchasing equine health products and medications.

The veterinary hospitals & clinics segment accounted for the largest market share in 2023, owing to their essential role in delivering comprehensive care for horses. The extensive infrastructure, specialized staff, and advanced equipment available at these institutions further contributed to their dominance.

North America is projected to register the fastest growth over the study period, owing to the advanced veterinary infrastructure, high level of investments in equine health, and the significant presence of major pharmaceutical and biotechnology companies.

The market in Asia Pacific is estimated to expand at a significant CAGR during the forecast period owing to the increasing investments in equine health infrastructure, rising awareness of animal welfare, and the expanding equestrian industry in countries such as China and Australia.

Zoetis Services LLC; Arthrex Inc.; Dechra; Ceva Sante Animale; Merck & Co., Inc.; Heska Corporation; Hallmarq Veterinary Imaging; ESAOTE SPA; Vetoquinol S.A.; IDEXX Laboratories, Inc.; Elanco; Covetrus Inc.; Cargill; and Biosig Instruments Inc. are among the global players in the equine healthcare market.

Polaris Market Research has segmented the equine healthcare market report on the basis of product, indication, activity, distribution channel, and region:

By Product Outlook (Revenue, USD Billion, 2019-2032)

  • Vaccines
  • Pharmaceuticals
  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory & Analgesics
  • Other Pharmaceuticals
  • Medicinal Feed Additives
  • Orthobiologics
  • Diagnostics
  • Diagnostic Test Kits
  • Diagnostic Equipment
  • Software
  • Practice Management Software
  • Imaging Software
  • Telehealth Software
  • Other Software
  • Other

By Indication Outlook (Revenue, USD Billion, 2019-2032)

  • Musculoskeletal Disorders
  • Parasitic Infections
  • Equine Herpes Virus
  • Equine Viral Arteritis (EVA)
  • Equine Influenza
  • West Nile Virus
  • Tetanus
  • Other

By Activity Outlook (Revenue, USD Billion, 2019-2032)

  • Sports/Racing
  • Recreation
  • Other

By Distribution Channel Outlook (Revenue, USD Billion, 2019-2032)

  • Veterinary Hospitals & Clinics
  • E-commerce
  • Equestrian Facilities
  • Other

By Regional Outlook (Revenue, USD Billion, 2019-2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Equine Healthcare Market Insights

  • 4.1. Equine Healthcare Market - Market Snapshot
  • 4.2. Equine Healthcare Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing horse population is driving the market
      • 4.2.1.2. Emergence of artificial intelligence (AI) In equine health propels the market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost associated with treatment is hindering the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Equine Healthcare Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Equine Healthcare Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Vaccines
    • 5.3.1. Global Equine Healthcare Market, by Vaccines, by Region, 2019-2032 (USD Billion)
  • 5.4. Pharmaceuticals
    • 5.4.1. Global Equine Healthcare Market, by Pharmaceuticals, by Region, 2019-2032 (USD Billion)
  • 5.5. Medicinal Feed Additives
    • 5.5.1. Global Equine Healthcare Market, by Medicinal Feed Additives, by Region, 2019-2032 (USD Billion)
  • 5.6. Orthobiologics
    • 5.6.1. Global Equine Healthcare Market, by Orthobiologics, by Region, 2019-2032 (USD Billion)
  • 5.7. Diagnostics
    • 5.7.1. Global Equine Healthcare Market, by Diagnostics, by Region, 2019-2032 (USD Billion)
  • 5.8. Software
    • 5.8.1. Global Equine Healthcare Market, by Software, by Region, 2019-2032 (USD Billion)
  • 5.9. Other
    • 5.9.1. Global Equine Healthcare Market, by Other, by Region, 2019-2032 (USD Billion)

6. Global Equine Healthcare Market, by Indication

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
  • 6.3. Musculoskeletal Disorders
    • 6.3.1. Global Equine Healthcare Market, by Musculoskeletal Disorders, by Region, 2019-2032 (USD Billion)
  • 6.4. Parasitic Infections
    • 6.4.1. Global Equine Healthcare Market, by Parasitic Infections, by Region, 2019-2032 (USD Billion)
  • 6.5. Equine Herpes Virus
    • 6.5.1. Global Equine Healthcare Market, by Equine Herpes Virus, by Region, 2019-2032 (USD Billion)
  • 6.6. Equine Viral Arteritis (EVA)
    • 6.6.1. Global Equine Healthcare Market, by Equine Viral Arteritis (EVA), by Region, 2019-2032 (USD Billion)
  • 6.7. Equine Influenza
    • 6.7.1. Global Equine Healthcare Market, by Equine Influenza, by Region, 2019-2032 (USD Billion)
  • 6.8. West Nile Virus
    • 6.8.1. Global Equine Healthcare Market, by West Nile Virus, by Region, 2019-2032 (USD Billion)
  • 6.9. Tetanus
    • 6.9.1. Global Equine Healthcare Market, by Tetanus, by Region, 2019-2032 (USD Billion)
  • 6.10. Other
    • 6.10.1. Global Equine Healthcare Market, by Other, by Region, 2019-2032 (USD Billion)

7. Global Equine Healthcare Market, by Activity

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
  • 7.3. Sports/Racing
    • 7.3.1. Global Equine Healthcare Market, by Sports/Racing, by Region, 2019-2032 (USD Billion)
  • 7.4. Recreation
    • 7.4.1. Global Equine Healthcare Market, by Recreation, by Region, 2019-2032 (USD Billion)
  • 7.5. Other
    • 7.5.1. Global Equine Healthcare Market, by Other, by Region, 2019-2032 (USD Billion)

8. Global Equine Healthcare Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.3. Veterinary Hospitals & Clinics
    • 8.3.1. Global Equine Healthcare Market, by Veterinary Hospitals & Clinics, by Region, 2019-2032 (USD Billion)
  • 8.4. E-commerce
    • 8.4.1. Global Equine Healthcare Market, by E-commerce, by Region, 2019-2032 (USD Billion)
  • 8.5. Equestrian Facilities
    • 8.5.1. Global Equine Healthcare Market, by Equestrian Facilities, by Region, 2019-2032 (USD Billion)
  • 8.6. Other
    • 8.6.1. Global Equine Healthcare Market, by Other, by Region, 2019-2032 (USD Billion)

9. Global Equine Healthcare Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Equine Healthcare Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Equine Healthcare Market - North America
    • 9.3.1. North America: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
    • 9.3.2. North America: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
    • 9.3.3. North America: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
    • 9.3.4. North America: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.3.5. Equine Healthcare Market - U.S.
      • 9.3.5.1. U.S.: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.3.6. Equine Healthcare Market - Canada
      • 9.3.6.1. Canada: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 9.4. Equine Healthcare Market - Europe
    • 9.4.1. Europe: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.5. Equine Healthcare Market - UK
      • 9.4.5.1. UK: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.6. Equine Healthcare Market - France
      • 9.4.6.1. France: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.7. Equine Healthcare Market - Germany
      • 9.4.7.1. Germany: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.8. Equine Healthcare Market - Italy
      • 9.4.8.1. Italy: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.9. Equine Healthcare Market - Spain
      • 9.4.9.1. Spain: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.10. Equine Healthcare Market - Netherlands
      • 9.4.10.1. Netherlands: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.11. Equine Healthcare Market - Russia
      • 9.4.11.1. Russia: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.12. Equine Healthcare Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.4.12.2. Rest of Europe: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.4.12.3. Rest of Europe: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.4.12.4. Rest of Europe: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 9.5. Equine Healthcare Market - Asia Pacific
    • 9.5.1. Asia Pacific: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.5. Equine Healthcare Market - China
      • 9.5.5.1. China: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.5.5.2. China: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.6. Equine Healthcare Market - India
      • 9.5.6.1. India: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.5.6.2. India: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.7. Equine Healthcare Market - Malaysia
      • 9.5.7.1. Malaysia: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.5.7.2. Malaysia: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.5.7.3. Malaysia: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.5.7.4. Malaysia: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.8. Equine Healthcare Market - Japan
      • 9.5.8.1. Japan: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.5.8.2. Japan: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.5.8.3. Japan: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.5.8.4. Japan: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.9. Equine Healthcare Market - Indonesia
      • 9.5.9.1. Indonesia: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.10. Equine Healthcare Market - South Korea
      • 9.5.10.1. South Korea: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.11. Equine Healthcare Market - Australia
      • 9.5.11.1. Australia: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.5.11.2. Australia: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.5.11.3. Australia: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.5.11.4. Australia: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.12. Equine Healthcare Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 9.6. Equine Healthcare Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.6.5. Equine Healthcare Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.6.6. Equine Healthcare Market - UAE
      • 9.6.6.1. UAE: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.6.6.2. UAE: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.6.6.3. UAE: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.6.6.4. UAE: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.6.7. Equine Healthcare Market - Israel
      • 9.6.7.1. Israel: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.6.8. Equine Healthcare Market - South Africa
      • 9.6.8.1. South Africa: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.6.8.2. South Africa: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.6.8.3. South Africa: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.6.8.4. South Africa: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.6.9. Equine Healthcare Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 9.7. Equine Healthcare Market - Latin America
    • 9.7.1. Latin America: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.7.5. Equine Healthcare Market - Mexico
      • 9.7.5.1. Mexico: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.7.6. Equine Healthcare Market - Brazil
      • 9.7.6.1. Brazil: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.7.7. Equine Healthcare Market - Argentina
      • 9.7.7.1. Argentina: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.7.8. Equine Healthcare Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Equine Healthcare Market, by Product, 2019-2032 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Equine Healthcare Market, by Indication, 2019-2032 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Equine Healthcare Market, by Activity, 2019-2032 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Zoetis Services LLC
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Arthrex Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Dechra
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Ceva Sante Animale
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Merck & Co., Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Heska Corporation
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Hallmarq Veterinary Imaging
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. ESAOTE SPA
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Vetoquinol S.A
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. IDEXX Laboratories, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Elanco
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Covetrus Inc
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Cargill
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Biosig Instruments Inc.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제